Skip to content
Medications

Mounjaro vs Zepbound: Same Drug, Different Name?

3 min readLast updated By Jeremy H., GLP-1 Nutrition Researcher
Mounjaro vs Zepbound: Same Drug, Different Name?
§

This article may contain affiliate links. If you click and make a purchase, we may earn a commission at no extra cost to you. Full disclosure policy

Mounjaro and Zepbound contain the exact same drug: tirzepatide. They're made by the same company (Eli Lilly). So why two names? It comes down to what they're approved for.

Quick Comparison

Mounjaro Zepbound
Active drug Tirzepatide Tirzepatide
Drug class Dual GIP/GLP-1 agonist Dual GIP/GLP-1 agonist
FDA approval Type 2 diabetes Weight management
Dose range 2.5 mg – 15 mg 2.5 mg – 15 mg
Injection Once weekly Once weekly
Maker Eli Lilly Eli Lilly

Helpful Tools for GLP-1 Management

Whether you're on Mounjaro or Zepbound, these products help manage your treatment:

  • Injection site rotation tracker — Proper rotation prevents skin irritation. An injection site chart helps you track where you injected.

  • Sharps container — Required for safe needle disposal. A sharps container is essential for home use.

  • Weekly pill organizer — Track your injection days alongside other medications. A weekly organizer helps you stay on schedule.

  • Water bottle — Staying hydrated helps reduce side effects. A large water bottle makes it easier to drink enough.

  • Ginger chews — For managing nausea. Ginger chews are convenient and effective.

GLPSpot may earn from qualifying purchases.

GLP-1 medication news, in plain English

New approvals, pens, pills, prices and label changes across GLP-1 medications. One free email a week.

Same Drug, Different Label

Mounjaro is approved for type 2 diabetes. Weight loss happens as a side effect.

Zepbound is approved for weight management. It's the same drug, but marketed and approved for a different purpose.

The doses are identical. The pen device may look slightly different. But the medicine inside is the same.

Why Does This Matter?

Insurance coverage. That's the main reason.

  • If you have diabetes, your insurance may cover Mounjaro.
  • If you're using it for weight loss, your insurance may cover Zepbound.
  • Some plans cover neither. Some cover both.

Your formulary will likely decide which one you get.

Weight Loss Results

Since they're the same drug, results are the same:

  • Average weight loss: ~15-22% of body weight at max dose (15 mg)
  • Trial length: 72 weeks
  • Results vary person to person

Side Effects

Identical for both:

  • Nausea (most common)
  • Diarrhea or constipation
  • Decreased appetite
  • Vomiting (less common)
  • Stomach pain
  • Fatigue

Side effects are worst when you start and after dose increases. Most people adjust within a few weeks.

Cost

How we check prices: our medication-cost methodology explains the sources behind the figures in this guide.

Both have a list price around $1,060/month. Your actual cost depends on:

  • Insurance coverage
  • Savings cards (Eli Lilly offers them for both)
  • Pharmacy pricing

Who Should Use Mounjaro?

  • You have type 2 diabetes
  • Your insurance covers Mounjaro
  • Your doctor prescribed it for blood sugar control

Who Should Use Zepbound?

  • Your main goal is weight loss
  • Your insurance covers Zepbound
  • You don't have diabetes

Can You Switch?

Yes, and it's straightforward since the drug is the same. Your dose stays the same. The main reason to switch is insurance.

Bottom Line

Mounjaro and Zepbound are the same drug with different FDA approvals. Pick the one your insurance covers for your specific health need.

Storage note: Both Mounjaro and Zepbound last only 21 days at room temperature after first use — much shorter than Ozempic's 56-day window. See our GLP-1 Storage Guide for the full storage comparison and what to do if your pen was left out.

Work with your healthcare provider to determine which medication is right for you. Individual results and experiences vary.

GLP-1 medication news, in plain English

New approvals, pens, pills, prices and label changes across GLP-1 medications. One free email a week.

We respect your privacy. Unsubscribe anytime.

Next up

A few related reads to keep your momentum.

Tirzepatide (Mounjaro) vs. Semaglutide (Ozempic): Nutrition Differences
Getting Started
Feb 25, 2026
Tirzepatide (Mounjaro) vs. Semaglutide (Ozempic): Nutrition Differences
Tirzepatide works differently—and your nutrition needs differ too. Here's what GLP beginners need to know when navigating Mounjaro versus Ozempic.
Tirzepatide Guide: Mounjaro and Zepbound Explained
Getting Started
Mar 20, 2026
Tirzepatide Guide: Mounjaro and Zepbound Explained
Tirzepatide is sold as Mounjaro and Zepbound. Here's what tirzepatide is, how it differs from semaglutide, and why the two brand names exist.
GLP-1 Cost Comparison 2026: What You'll Actually Pay
Cost
Apr 3, 2026
GLP-1 Cost Comparison 2026: What You'll Actually Pay
Compare real GLP-1 costs in 2026, with or without insurance — list prices, copays, savings cards, LillyDirect self-pay, generics, Medicare Bridge, Foundayo pricing, and a budgeting framework so you know your true monthly spend.
Zepbound Savings Card 2026: Who Qualifies and How to Lower Monthly Cost
Guides
Mar 29, 2026
Zepbound Savings Card 2026: Who Qualifies and How to Lower Monthly Cost
Learn who may qualify for Zepbound savings in 2026, why pharmacy claims fail, and a 5-step workflow to estimate and reduce monthly out-of-pocket cost.
Does Ozempic Need Refrigeration? US GLP-1 Storage Rules by Device
Dosage Guide
Apr 8, 2026
Does Ozempic Need Refrigeration? US GLP-1 Storage Rules by Device
US storage rules by product and device: unopened versus in-use pens and vials, room-temperature limits, travel, power outages, and pharmacist advice.
Zepbound vs Retatrutide: Available Treatment vs Investigational Triple Agonist
Medications
Apr 4, 2026
Zepbound vs Retatrutide: Available Treatment vs Investigational Triple Agonist
Retatrutide is an investigational triple-hormone drug not yet FDA-approved. TRIUMPH-1 showed 28.3% weight loss at 80 weeks. See how it compares to Zepbound and when it may be available.

Related articles

Written by
J
Jeremy H.
GLP-1 Nutrition Researcher

Nutrition researcher and founder of The GLPSpot. Jeremy built this site after watching friends and family struggle with the nutritional challenges of reduced appetite on GLP-1 medications — loss of muscle mass, dehydration, and nutrient deficiencies.

Published:
Medical Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment.